Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The National Institute for Health Research (NIHR) Oxford Biomedical Research (BRC) is holding a series of free events including talks, tours and exhibitions, on the latest advances in research to improve healthcare.

The BRC brings together researchers and clinicians from Oxford University Hospitals NHS Trust and Oxford University to improve healthcare through translational research - taking laboratory research into a clinical setting.  

From 6- 21 March, the BRC ‘Open Weeks’ will showcase some of this world-leading research. This ties in with the Oxfordshire Science Festival and British Science Week.

Events are taking place at a host of venues including the Oxford Natural History Museum and Oxford’s hospitals. All events are free and open to all.

Highlights include a behind–the-scenes look at state-of-the-art scanning facilities.

There will be talks on the latest research into the heart, cancer, blood, genomic medicine and more, as well as interactive exhibitions explaining how technology is revolutionising healthcare in hospital and at home. Vasiliki Kiparoglou, Head of Operations, NIHR Oxford BRC, said:“Oxford  has long been at the forefront of medical research, whether it is the genetic and molecular basis of disease, the latest advances in neuroscience, or clinical studies in cancer, diabetes, heart disease, stroke and other conditions. This is a fantastic opportunity to learn about the benefits to patients of the latest developments in healthcare research.”

More information on the Oxford BRC Open Weeks

 

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.